EU fines AstraZeneca €60m
European Union antitrust regulators today fined British pharmaceutical company AstraZeneca €60m for keeping prices on its ulcer drug product artificially high.
EU spokesman Jonathan Todd said the company infringed EU competition rules between 1993 and 2000.
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.





